Grid Therapeutics, another Triangle company working on a promising anti-cancer immunotherapy, has raised a chunk of a combined debt and equity round. Its first treatment offers hope to certain small cell lung cancer patients who have had the disease recurr.
Read MorePrecision Biosciences gets FDA clearance for clinical trial of immunotherapy that could be “transformative” in treating two forms of blood cancer.
Read MoreDrug development company Heat Biologics reported a larger-than-expected second quarter loss due to higher research and development expenses
Read MoreHeat Biologics, which is developing immunotherapies to battle cancer, has sold nearly $20.7 million in a stock and warrants offering.
Read More
